BioVie
BIVI
53 hedge funds and large institutions have $2.42M invested in BioVie in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 13 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
0% more ownership
Funds ownership: 0.05% → 0.05% (+0%)
5% less funds holding
Funds holding: 56 → 53 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
59% less capital invested
Capital invested by funds: $5.95M → $2.42M (-$3.53M)
69% less call options, than puts
Call options by funds: $295K | Put options by funds: $952K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$838K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$457K |
| 3 |
Morgan Stanley
New York
|
+$333K |
| 4 |
State Street
Boston,
Massachusetts
|
+$259K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.56M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$343K |
| 3 |
MCM
Moore Capital Management
New York
|
-$316K |
| 4 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$68.2K |
| 5 |
Millennium Management
New York
|
-$67K |
BIVI Hedge Fund Activity: Q4 2023 in Review
53 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2023, worth a combined $2.42M — down 59% from $5.95M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BIVI and 10 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 21 added.
The largest buyer was BlackRock, adding an estimated $838K. The largest seller was Ikarian Capital, exiting entirely with an estimated $1.56M sold.
- 53 institutional investors held BioVie (BIVI) as of Q4 2023, down from 56 in Q3 2023.
- Funds reported $2.42M of BioVie stock for Q4 2023, down 59% quarter-over-quarter.
- 10 funds opened new BioVie positions in Q4 2023 and 13 closed out, a net change of -3 holders.
- The largest BioVie buyer in Q4 2023 was BlackRock, an estimated $838K added.
- The largest BioVie seller in Q4 2023 was Ikarian Capital, an estimated $1.56M sold.
Based on aggregated 13F filings for Q4 2023.